Peter C. Lucas

14.1k total citations · 1 hit paper
163 papers, 8.4k citations indexed

About

Peter C. Lucas is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Peter C. Lucas has authored 163 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cancer Research, 81 papers in Oncology and 54 papers in Molecular Biology. Recurrent topics in Peter C. Lucas's work include Colorectal Cancer Treatments and Studies (36 papers), Cancer Genomics and Diagnostics (34 papers) and Genetic factors in colorectal cancer (26 papers). Peter C. Lucas is often cited by papers focused on Colorectal Cancer Treatments and Studies (36 papers), Cancer Genomics and Diagnostics (34 papers) and Genetic factors in colorectal cancer (26 papers). Peter C. Lucas collaborates with scholars based in United States, Canada and Germany. Peter C. Lucas's co-authors include Kenneth Longo, Ormond A. MacDougald, Christina N. Bennett, Sarah E. Ross, Nahid Hemati, Robin L. Erickson, Gabriel Núñez, Daryl K. Granner, Linda M. McAllister‐Lucas and Naohiro Inohara and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter C. Lucas

158 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of Adipogenesis by Wnt Signaling

2000 1.6k citations Peter C. Lucas et al. profile →

Peers

Countries citing papers authored by Peter C. Lucas

Since Specialization

Citations

This map shows the geographic impact of Peter C. Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Lucas more than expected).

Fields of papers citing papers by Peter C. Lucas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Lucas. The network helps show where Peter C. Lucas may publish in the future.

Co-authorship network of co-authors of Peter C. Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Lucas. A scholar is included among the top collaborators of Peter C. Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Lucas. Peter C. Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma 2025 ·Journal of Clinical Investigation ·(unknown), Lisa M. Maurer, (unknown), (unknown), Linda R. Klei, (unknown), Juliana H. Azambuja, Marcelo J. Murai, Ahmed S.A. Mady, Ejaz Ahmad, (unknown), (unknown), (unknown), Prasanna Ekambaram, Zaneta Nikolovska‐Coleska, Bill B. Chen, Linda M. McAllister‐Lucas, Peter C. Lucas	3
2	Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial 2024 ·Clinical Cancer Research ·Eleftherios P. Mamounas, Hanna Bandos, Priya Rastogi, (unknown), Kai Treuner, Peter C. Lucas, Charles E. Geyer, Louis Fehrenbacher, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Soonmyung Paik, Sandra M. Swain, Dennis C. Sgroi, Catherine A. Schnabel, Norman Wolmark	7
3	Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer 2024 ·npj Precision Oncology ·Fangyuan Chen, Sayali Onkar, Jian Zou, Yujia Li, (unknown), (unknown), George C. Tseng, Peter C. Lucas, Tullia C. Bruno, Dario A.A. Vignali, Julia Foldi, Marija Balić, Adrian V. Lee, Steffi Oesterreich	1
4	888 Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma 2023 ·SHILAP Revista de lepidopterología ·Ryan C. Augustin, (unknown), (unknown), Marion Joy, (unknown), (unknown), Peter C. Lucas, (unknown), Cindy Sander, Brian R. Isett, Diwakar Davar, Yana G. Najjar, Hassane M. Zarour, John M. Kirkwood, Jason J. Luke, Riyue Bao	1
5	BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma 2022 ·Cancer Research Communications ·Lisa M. Maurer, (unknown), (unknown), (unknown), Claire M. Julian, Nathanael G. Bailey, Michelle F. Jacobs, Chandan Kumar‐Sinha, (unknown), (unknown), Kurt R. Weiss, Katherine A. Janeway, Rajen Mody, Peter C. Lucas, Linda M. McAllister‐Lucas, Kelly M. Bailey	10
6	The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes 2022 ·Cancer Discovery ·Sayali Onkar, Neil Carleton, Peter C. Lucas, Tullia C. Bruno, Adrian V. Lee, Dario A.A. Vignali, Steffi Oesterreich	133
7	Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences 2021 ·Breast Cancer Research ·Nolan Priedigkeit, Kai Ding, William Horne, Jay K. Kolls, Tian Du, Peter C. Lucas, Jens‐Uwe Blohmer, Carsten Denkert, (unknown), Barbara Ingold‐Heppner, Steffi Oesterreich, Adrian V. Lee	24
8	MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial Cells 2020 ·The Journal of Immunology ·Danielle N. Alfano, Linda R. Klei, (unknown), (unknown), Peter J. Gough, Kevin P. Foley, John Bertin, Tina L. Sumpter, Peter C. Lucas, Linda M. McAllister‐Lucas	12
9	Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers 2019 ·BMC Cancer ·(unknown), Huabo Wang, Daniel P. Normolle, Wei Chen, Qi Yan, Peter C. Lucas, Panayiotis V. Benos, Edward V. Prochownik	6
10	FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype 2019 ·npj Breast Cancer ·Kevin M. Levine, Nolan Priedigkeit, Ahmed Basudan, Nilgun Tasdemir, Matthew J. Sikora, Ethan S. Sokol, Ryan J. Hartmaier, Kai Ding, (unknown), Rebecca Watters, Kurt R. Weiss, Jens‐Uwe Blohmer, Carsten Denkert, (unknown), Maria Margarete Karsten, M.M. Boisen, Esther Elishaev, Peter C. Lucas, Adrian V. Lee, Steffi Oesterreich	41
11	Targeted mutation detection in breast cancer using MammaSeq™ 2019 ·Breast Cancer Research ·(unknown), Rekha Gyanchandani, (unknown), Grzegorz T. Gurda, Peter C. Lucas, Ryan J. Hartmaier, Adam Brufsky, Shannon Puhalla, Amir Bahreini, (unknown), Abigail I. Wald, Yuri E. Nikiforov, Marina N. Nikiforova, Steffi Oesterreich, Adrian V. Lee	22
12	Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer 2018 ·Molecular Cancer Research ·Ahmed Basudan, Nolan Priedigkeit, Ryan J. Hartmaier, Ethan S. Sokol, Amir Bahreini, Rebecca Watters, M.M. Boisen, Rohit Bhargava, Kurt R. Weiss, Maria Margarete Karsten, Carsten Denkert, Jens‐Uwe Blohmer, José Pablo Leone, Ronald L. Hamilton, Adam Brufsky, Esther Elishaev, Peter C. Lucas, Adrian V. Lee, Steffi Oesterreich	24
13	G protein-coupled receptor kinase-2-deficient mice are protected from dextran sodium sulfate-induced acute colitis 2018 ·Physiological Genomics ·(unknown), (unknown), Taehyung Lee, Peter C. Lucas, Laura R. McCabe, Narayanan Parameswaran	9
14	Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations 2018 ·PLoS ONE ·Rekha Pal, Ning Wei, Nan Song, Shaoyu Wu, Rim S. Kim, Ying Wang, Patrick G. Gavin, Peter C. Lucas, Ashok Srinivasan, Carmen J. Allegra, Samuel A. Jacobs, Soonmyung Paik, John C. Schmitz, Katherine L. Pogue–Geile	8
15	The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer 2017 ·Cancer Research ·Prasanna Ekambaram, (unknown), (unknown), Dong Hu, Saigopalakrishna S. Yerneni, Phil G. Campbell, Netanya Pollock, Linda R. Klei, Vincent J. Concel, Phillip C. Delekta, Arul M. Chinnaiyan, Scott A. Tomlins, Daniel R. Rhodes, Nolan Priedigkeit, Adrian V. Lee, Steffi Oesterreich, Linda M. McAllister‐Lucas, Peter C. Lucas	67
16	Role of G protein-coupled receptor kinase-6 in Escherichia coli lung infection model in mice 2017 ·Physiological Genomics ·Taehyung Lee, Nandakumar Packiriswamy, Eun-Hee Lee, Peter C. Lucas, Laura R. McCabe, Narayanan Parameswaran	4
17	Aberrant Huntingtin Interacting Protein 1 in Lymphoid Malignancies 2007 ·Cancer Research ·Sarah V. Bradley, Mitchell R. Smith, Teresa S. Hyun, Peter C. Lucas, Lina Li, (unknown), Indira Joshi, Fang Jin, Theodora S. Ross	25
18	Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival 2002 ·Journal of Clinical Investigation ·Dinesh S. Rao, Teresa S. Hyun, (unknown), Ikuko F. Mizukami, Mark A. Rubin, Peter C. Lucas, Martin G. Sanda, Theodora S. Ross	71
19	Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival 2002 ·Journal of Clinical Investigation ·Dinesh S. Rao, Teresa S. Hyun, (unknown), Ikuko F. Mizukami, Mark A. Rubin, Peter C. Lucas, Martin G. Sanda, Theodora S. Ross	84
20	Hepatic Nuclear Factor 3- and Hormone-Regulated Expression of the Phosphoenolpyruvate Carboxykinase and Insulin-Like Growth Factor-Binding Protein 1 Genes 1995 ·Molecular and Cellular Biology ·Richard M. O’Brien, Edouard L. Noisin, Adisak Suwanichkul, Tomoyuki Yamasaki, Peter C. Lucas, Jen-Chywan Wang, D.R. Powell, Daryl K. Granner	200

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact